# The regulation of ovarian aging by H19 and let-7

> **NIH NIH R01** · YALE UNIVERSITY · 2020 · $360,125

## Abstract

PROJECT SUMMARY/ABSTRACT
The mean age of first-time mothers is on the rise, with serious consequences for maternal health and that of
their offspring. Older maternal age is strongly associated with birth defects, miscarriage, and infertility. These
poor reproductive outcomes can frequently be traced back to defects in follicular and oocyte quantity and quality
that occur with ovarian aging. A continuous decline in the quantity of ovarian follicles (i.e. the “ovarian reserve”)
occurs during reproductive aging, as the pool of primordial follicles is continuously depleted. Additionally, oocyte
quality declines as follicles and oocytes accumulate DNA damage over time, a process which accelerates even
more rapidly when the ovary is exposed to gonadotoxins. There is therefore an urgent need to better understand
the mechanisms that control follicular and oocyte quantity and quality in order to support the health of women
and their children. The noncoding RNAs H19 and let-7 play essential roles in mammalian development, but little
is known about their role in ovarian follicle growth and oocyte function. We have uncovered a plausible
mechanism for noncoding-RNA-based regulation of follicular health via the H19/let-7 pair. We previously showed
that H19 binds and antagonizes the miRNA let-7. We also demonstrated that in the absence of H19, ovarian
AMH expression is decreased, follicular recruitment is accelerated, and fertility is compromised. We have
observed that AMH has a functional let-7 binding site, suggesting a ncRNA-mediated mechanism for AMH
regulation by H19 via let-7. Moreover, our preliminary data suggests altered response to DNA damage in the
absence of H19. Thus, there is plausible mechanistic insight into, and strong support for, the role of H19 and let-
7 in the regulation of follicular/oocyte recruitment and function. In Aim 1, we will determine the role of H19 in E2-
and AMH-mediated regulation of follicle quantity. In Aim 2, we will determine whether ovaries of H19KO mice
are more susceptible to DNA damage than their WT counterparts. Lastly, for Aim 3, we will determine whether
the abnormal follicular development and expression of DNA damage genes observed in H19KO mice is
mediated via let-7 and identify changes in the transcriptome of somatic cells and oocytes related to loss of
H19. Our approach is innovative because it represents a substantive departure from the status quo by
defining noncoding RNAs (ncRNAs) as major regulators of oocyte quantity and quality, and has the potential to
lead to novel, ncRNA-based treatments for a broad range of reproductive disease states.

## Key facts

- **NIH application ID:** 10120190
- **Project number:** 1R01HD101475-01A1
- **Recipient organization:** YALE UNIVERSITY
- **Principal Investigator:** Amanda Nicole Kallen
- **Activity code:** R01 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2020
- **Award amount:** $360,125
- **Award type:** 1
- **Project period:** 2020-09-18 → 2025-06-30

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10120190

## Citation

> US National Institutes of Health, RePORTER application 10120190, The regulation of ovarian aging by H19 and let-7 (1R01HD101475-01A1). Retrieved via AI Analytics 2026-05-22 from https://api.ai-analytics.org/grant/nih/10120190. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*
